Wird geladen...
Fentanyl for the Treatment of Tumor-Related Breakthrough Pain
BACKGROUND: Breakthrough cancer pain (BTCP) is common among cancer patients and markedly lowers their quality of life. The treatment for BTCP episodes that is recommended in current guidelines involves extended-release formulations in combination with rapid-onset and short-acting opioids. In the pas...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Deutscher Arzte Verlag
2013
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3648890/ https://ncbi.nlm.nih.gov/pubmed/23671467 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3238/arztebl.2013.0271 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|